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Abstract 31 
This study had two specific objectives; 1) to examine the individual variation in the pattern of 32 
cardiac troponin I (cTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) response 33 
to high intensity rowing exercise, and 2) to establish if individual heterogeneity in biomarker 34 
appearance was influenced by athletic status (elite vs. amateur). We examined cTnI and NT-35 
proBNP in 18 elite and 14 amateur rowers before and 5 min, 1, 3, 6, 12, and 24 h after a 30 36 
min maximal rowing test. Peak post-exercise cTnI (pre: 0.014 ± 0.030, peak post: 0.058 ± 37 
0.091 µg.L
-1
, p = 0.000) and NT-proBNP (pre: 15 ± 11, peak post: 31 ± 19 ng.L
-1
, p = 0.000) 38 
were elevated. Substantial individual heterogeneity in peak and time course data noted for 39 
cTnI. Peak cTnI exceeded the upper reference limit (URL) in 9 elite and 3 amateur rowers. 40 
No rower exceeding the URL for NT-proBNP. Elite rowers had higher baseline (0.019 ± 41 
0.038 vs. 0.008 ± 0.015 µg.L
-1
; p = 0.003) and peak post-exercise cTnI (0.080 ± 0.115 vs. 42 
0.030 ± 0.029 µg.L
-1
; p = 0.022) than amateur rowers but the change with exercise was 43 
similar between groups. There were no significant differences in baseline and peak post-44 
exercise NT-proBNP between groups. In summary, marked individuality in cTnI response 45 
was noted to a short but high intensity rowing bout. Athlete status did not seem to mediate 46 
the change in cardiac biomarkers to high intensity exercise. 47 
 48 
Keywords: exercise; cTnI; NT-proBNP; athletic status; rowing, elite athletes, amateur athlete 49 
 50 
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Introduction 56 
An increasing number of studies have described the elevation of cardiac troponin I (cTnI), a 57 
biomarker of cardiac cell necrosis, and N-terminal pro-brain nariuretic peptide (NT-proBNP), 58 
a biomarker of cardiac dysfunction, after prolonged and strenuous exercise (Scharhag et al. 59 
2008; Shave et al. 2010a). The cardiac biomarker response to short-duration, high-intensity 60 
exercise is largely unknown although some have suggested that within the endurance exercise 61 
domain cTnI increased with exercise intensity (Legaz-Arrese et al. 2011; Serrano-Ostáriz et 62 
al. 2011). Shave et al. (2010b) are one of the few groups to have studied the cTnI response 63 
shorter, high-intensity bouts of exercise. In spite of the limited volume of exercise (30 min 64 
all-out treadmill run) cTnI was elevated during recovery in 75% of athletes (Shave et al. 65 
2010b). 66 
Importantly Shave et al. (2010b) observed that the cTnI appearance during recovery was 67 
markedly heterogeneous and confirmed similar individuality of response noted in field based 68 
studies of prolonged exercise (Shave et al. 2010a) as well as an observation from a meta-69 
analysis (Shave et al. 2007). The percentage of individuals with post-exercise cTnI or cTnT 70 
levels above the upper reference limit (URL) has varied from 0% (Roth et al. 2007) to 100% 71 
(Middleton et al. 2008) in individual studies but this may partially represent the “lottery” of a 72 
single post-exercise blood test. It is important that in on-going cardiac biomarker research 73 
that multiple post-exercise blood draws occur to fully understand any heterogeneity in cTnI 74 
or NTpro-BNP peak concentrations as well as recovery kinetics (Middleton et al. 2008). 75 
The influence of exercise intensity on NT-proBNP release is less well known. Within the 76 
endurance exercise domain data suggests that NT-proBNP increase may be more influenced 77 
by exercise duration (Serrano-Ostáriz et al. 2009) but studies involving shorter bouts of high 78 
intensity exercise in well-trained athletes are limited.  79 
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Individual variability in biomarker response in the extant literature has been speculated to be, 80 
at least partially, related to training or “athletic” status. It has been suggested that highly-81 
trained individuals have lower post-exercise cTnI and NT-proBNP release (Mehta et al. 2012; 82 
Neilan et al. 2006). Indeed, the only two previous studies on elite athletes reported normal 83 
post-exercise cardiac biomarker levels (Bonetti et al. 1996; König et al. 2003). Contrary, we 84 
have recently observed in untrained subjects that a controlled endurance training intervention 85 
resulted in higher pre- and post-exercise values of cTn with no changes in NT-proBNP 86 
(Legaz-Arrese et al., 2015). Currently, the influence of training level on cardiac biomarker 87 
release has not yet been evaluated in a controlled study with disparate groups in terms of 88 
training or athletic status completing a similar (relative) high intensity exercise bout. Finally, 89 
it has been postulated that increases in both biomarkers may be dependent on their respective 90 
resting values (Legaz Arrese et al. 2005; Serrano-Ostáriz et al. 2011) although this construct 91 
has not been studied in different athlete groups. 92 
Consequently, the purpose of the present study was to determine the cardiac biomarker 93 
response to a short duration, high intensity bout of rowing with specific emphasis on detailing 94 
individual responses across multiple assessment points during a 24 hr recovery period. A 95 
secondary purpose was to determine the influence of athlete status on cTnI and NT-proBNP 96 
release by comparing two cohorts; amateur and elite rowers. 97 
 98 
Material and Methods 99 
 100 
Participants 101 
Thirty-two male rowers were recruited from a large Rowing Club in Spain through an open 102 
invitation to all of its members. Volunteers included elite rowers (n = 18) who had at least 3 103 
yr of competitive history at the national or international level (1 world champion, 1 under-23 104 
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world champion, 1 Olympic competitor, 2 Spanish champions, and 3 Spanish sub-105 
champions) and were training ≥5 days per week and non-competitive amateur rowers (n = 106 
14) who trained ≤3 days per week. All rowers provided informed written consent. The study 107 
followed the ethical guidelines of the Declaration of Helsinki and was approved by the 108 
Research Ethics Committee of the Government of Aragón (CEICA; Spain). 109 
 110 
Research Design and Protocols 111 
All rowers attended a preliminary testing session 1 week before the main study was 112 
performed. At this initial testing body height was measured to the nearest 0.1 cm (SECA 225 113 
SECA, Hamburg, Germany). Body mass was determined to the nearest 0.05 kg (SECA 861, 114 
SECA, Hamburg, Germany). A questionnaire was completed to obtain personal data, 115 
performance level, training history, and history of any cardiac symptoms. Exclusion criteria 116 
were a significant personal or early family history of cardiovascular disease and/or abnormal 117 
ECG at baseline examination. 118 
The rowers then performed a progressive incremental test to exhaustion on a Concept II 119 
rowing ergometer (Model C, Morrisville, VT, USA) to determine the maximal heart rate 120 
(HR) (Polar Electro Oy, Kempele, Finland). Prior to the test, the rowers completed a self-121 
paced 5-min warm-up (HR <130 beats.min
-1
). The test began at a workload of 150 W (elite 122 
rowers) or 75 W (amateur rowers) with workload increments of 50 W every 3 min until 123 
exhaustion. Strong verbal encouragement was provided to all participants. 124 
After a minimum of 7 days all participants returned to the laboratory to complete the 30 min 125 
rowing test. All participants were fully habituated to the 30 min all-out rowing test protocol 126 
and were asked to abstain from strength training and strenuous exercise for 48 h before 127 
testing. All high-intensity testing sessions occurred at 11:00 am in a sports hall at a 128 
temperature of 18-21 °C and a relative humidity of 50-60%. The rowers completed a self-129 
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paced 5-min warm-up (HR <130 beats.min
-1
) followed by a 30-min “all-out” rowing test. 130 
Pairs of rowers competed side-by-side to mimic a regular competition and again strong verbal 131 
encouragement was provided. During the test HR was recorded continuously via a Polar HR 132 
monitor (Polar Electro Oy, Kempele, Finland) and downloaded using Polar Precision 133 
Performance software (v. 3.0). The mean power output (W) and distance covered were 134 
recorded every 5 min from the rowing ergometer screen. Immediately after the test was 135 
completed, the participants rated the test for perceived exertion (RPE) (Borg and Kaijser 136 
2006). Venous blood samples were taken before, immediately after (5 min), as well as 1, 3, 6, 137 
12, and 24 h after exercise to assess serum cardiac-specific biomarkers. 138 
 139 
Blood Sampling and Analysis 140 
Blood samples were drawn by repetitive venipuncture from an antecubital vein and quickly 141 
centrifuged. The serum and plasma were drawn off and stored at −80 °C for later analysis. 142 
cTnI was analyzed from samples of EDTA (ethylenediaminetetraaceitic acid) plasma with the 143 
Access AccuTnI assay (Beckman Coulter, Fullerton, CA, USA). The imprecision profile of 144 
839 duplicate samples showed 10% and 20% coefficients of variation values of 0.014 and 145 
0.008 µg.L
-1
, respectively. The URL for cTnI, defined as the 99th percentile of healthy 146 
participants, was 0.04 µg.L
-1
 (Eggers et al. 2007). NT-proBNP was analyzed in the serum 147 
with an Elecsys proBNP electrochemiluminescent immunoassay on the Roche Elecsys 1010 148 
(Roche Diagnostics, Lewes, United Kingdom) with an analytical range of 5–35,000 ng.L
-1
 149 
and intra- and interassay imprecisions of 0.7–1.6% and 5.3–6.6%, respectively. The URL for 150 
NT-proBNP was considered to be 125 ng.L
-1
 (Silver et al. 2004).  151 
 152 
Statistical analysis 153 
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Statistical analyses were performed using the IBM Statistical Package for the Social Sciences 154 
(IBM SPSS Statistics, v. 20.0 for WINDOWS). Cohort data are presented as the mean ± 155 
standard deviation unless otherwise stated. Kolmogorov-Smirnov tests were used to check for 156 
normal distribution and data for cTnI and NT-proBNP were log-transformed prior to 157 
statistical testing. To measure the impact of sampling time during recovery (pre, 5 min, 1, 3, 158 
6, 12, and 24 h post-exercise) as well as athletes status (elite and amateur) upon cTnI and NT-159 
proBNP mixed model 2-way ANOVAs were performed with post-hoc Bonferroni tests 160 
employed when appropriate. The association between the exercise increase in both 161 
biomarkers and other relevant variables (e.g., baseline biomarker concentration, mean and 162 
max exercise HR) were assessed using bivariate Pearson’s product-moment correlation 163 
coefficients. The values were considered to be significant if p < 0.05. 164 
 165 
Results 166 
The characteristics of the elite and amateur rowers are shown in Table 1. The elite rowers had 167 
more years of training, greater weekly training frequency, and higher weekly training volume 168 
(all p < 0.05). Performance during the grade rowing test was greater in the elite rowers (294 ± 169 
18 W vs. 211 ± 44 W; p = 0.000) whereas maximum HR was similar between groups (elite: 170 
196 ± 7 beats.min
-1
; amateur 193 ± 9 beats.min
-1
; p = 0.372). 171 
 172 
Maximal 30-min rowing test 173 
All of the subjects completed the maximal 30-min rowing test and every blood draw. 174 
Performance during the 30 min all out test was substantially greater in the elite athlete (Table 175 
2). Whilst mean HR was higher in the elite (180 ± 7 beats.min
-1
) compared to the amateur 176 
rowers (171 ± 12 beats.min
-1
; p = 0.023) there was no difference in the maximum HR (elite 177 
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rowers: 195 ± 7 beats.min
-1
, amateur rowers: 188 ± 11 beats.min
-1
; p = 0.061) or RPE (elite 178 
rowers: 8.7 ± 0.5, amateur rowers: 8.6 ± 0.5; p = 0.536). 179 
 180 
cTnI release 181 
A significant main effect of sampling time was observed for cTnI with an elevation at 3-, 6-, 182 
and 12-h post-exercise compared to baseline (p = 0.000) (Table 3). All participants presented 183 
with an increase in cTnI post-exercise with the URL for cTnI exceeded by 2 rowers at all 184 
measurements points and another 10 rowers (8 elite and 2 amateur) having sporadic data 185 
points above the URL during recovery (Fig. 1). The maximum post-exercise cTnI was 186 
observed at 3 h in 11 individuals, 6 h in 19 individuals, and 12 h of recovery in 2 individuals. 187 
A significant main effect for athlete status was observed with cTnI data higher in elite rowers 188 
including pre-exercise values (amateur: 0.008 ± 0.015 µg.L
-1
; elite: 0.019 ± 0.038 µg.L
-1
; p = 189 
0.003). There was no significant interaction of test time and athlete status with respect to 190 
cTnI (p = 0.311). In support of this the maximal increase in cTnI (peak-baseline) was not 191 
significantly different between groups (elite: 0.062 ± 0.083 µg.L
-1
; amateur: 0.023 ± 0.021 192 
µg.L
-1
; p = 0.145). The absolute post-exercise cTnI values were significantly correlated with 193 
the basal values (r = 0.88, p = 0.000) as well as mean exercise HR (r = 0.35, p = 0.048) 194 
 195 
NT-proBNP release 196 
There was a main effect of time with an increase in NT-proBNP from pre-exercise at 5 min, 197 
1-, 3-, 6-, 12-, and 24-h post-exercise (p = 0.001; Table 3). There was a rise in NT-proBNP 198 
post exercise in all subjects but the URL was not exceeded by any subject (Fig. 2). The 199 
maximum post-exercise NT-proBNP values were observed at 5 min in 10 individuals, 1 h for 200 
4 individuals, 6 h for 7 individuals, 12 h for 4 individuals, and 24 h for 11 individuals. There 201 
was no significant main effect of athlete status on NT-proBNP data and there was no time by 202 
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athlete status interaction effect. In support of this latter point there was no difference between 203 
the elite and amateur rowers with respect to the peak NT-proBNP increase (14 ± 11 vs. 18 ± 204 
13 ng.L
-1
, respectively; p = 0.470). Basal NT-proBNP values were significantly correlated 205 
with the maximum post-effort values (r = 0.83, p = 0.000) but there was no correlation 206 
between change in NT-proBNP and cTnI data.  207 
 208 
Discussion 209 
The main findings of this study were; (1) a single 30-min bout of “all-out” rowing exercise 210 
resulted in a significant increase in the cTnI and NT-proBNP in both elite and amateur 211 
rowers, (2) significant individual heterogeneity in peak cTnI during recovery was noted with 212 
the URL for cTnI exceeded in 12/32, (3) less individual variability was apparent in peak NT-213 
proBNP response with no data point exceeded the URL, (4) baseline and post-exercise cTnI 214 
data were higher in elite rowers, but (5) the rowing-induced changes in cTnI and NT-proBNP 215 
were independent of athlete status.  216 
 217 
Post-exercise cTnI peak and kinetics in elite and amateur rowers  218 
Our results in rowers extend the findings of Shave et al. (2010b) who employed a 30 min 219 
high intensity run and demonstrate that cTnI is elevated following short-duration, high-220 
intensity exercise in non-elite athletes. An elevation in cTnI occurred in all participants 221 
despite the relatively short duration and limited exercise volume. In prolonged exercise there 222 
is some evidence to suggest that cTnI release is positively associated with exercise intensity 223 
(Fu et al. 2009; Serrano-Ostáriz et al. 2011; Shave et al. 2007). Whilst the current study does 224 
not compare exercise intensities it adds to the extant data that different types and intensities 225 
of exercise can stimulate an increase in circulating cTnI. According to the results of Shave et 226 
al. (2010b) cTnI release following short-duration intense exercise may be as common as 227 
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when prolonged exercise trials are studied and the current study supports this contention. 228 
This also underscores the necessity to complete blood draws during recovery (Middleton et 229 
al. 2008).  230 
To our knowledge, this study is the first to demonstrate cTnI release with exercise in elite 231 
athletes with values that exceed the URL in some, but not all, participants. Previously, only 232 
two studies had evaluated cTnI release in elite athletes. Bonetti et al. (1996) analyzed 25 233 
cyclists participating in the Giro d’Italia and reported detectable cTnT values in only 5 234 
athletes; moreover, these values were below the cut-offs considered to be indicative of 235 
myocardial insult. Similarly, König et al. (König et al. 2003) reported normal post-exercise 236 
cTnT levels in 11 professional road cyclists. Both studies were constrained by limited blood 237 
sampling (pre- and post-exercise design) and by less-sensitive measurement equipment.  238 
Despite the fact that all participants experienced a rise in cTnI post-exercise the magnitude of 239 
peak post-exercise levels was variable, which also supports the data from Shave et al. 240 
(2010b). Recent studies have also demonstrated “positive” high sensitivity cTnT (hs-cTnT) 241 
values after prolonged exercise in most subjects (86-94%) (Mingel et al. 2009; Saravia et al. 242 
2010; Scherr et al. 2011; Tian et al. 2012), but with marked heterogeneity in peak hs-cTnT 243 
(Scherr et al. 2011; Tian et al. 2012). It is not known what personal, environmental or 244 
exercise-related factors mediate the heterogeneity and this requires on-going study. Whilst 245 
we observed variability in the peak cTnI values recorded 94% of participants recorded their 246 
peak cTnI between 3 or 6 h which suggests some consistency in cTnI kinetics and agrees 247 
with previous data gathered after a treadmill run (Tian et al. 2012). 248 
As in previous studies (Legaz-Arrese et al. 2011; Serrano-Ostáriz et al. 2011), it is interesting 249 
that the main factor that significantly predicted post-exercise values of cTnI was their 250 
respective pre-exercise values. In a broad range of pathologies and patient groups baseline 251 
cTn values are repeatedly and robustly associated with adverse cardiovascular prognosis and 252 
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mortality (deFilippi et al. 2010). In healthy population little attention has been focused to the 253 
variability of baseline cTn values and whether this variability may have clinical significance. 254 
On this matter, our results provide that the athletic status may be one of the factors that 255 
determine the heterogeneity in baseline cTnI. Further research into the factors associated with 256 
the inter-subject variability in the baseline values of cTn are required. 257 
Certain authors suggest that the post-exercise cTnI release is greater in less well-trained 258 
individuals (Fortescue et al. 2007; Mehta et al. 2012; Mingels et al. 2009; Neilan et al. 2006). 259 
However, other studies did not observe any relationship between training level and cTnI 260 
release (Eijsvogels et al. 2015; Hubble et al. 2009; Jassal et al. 2009; Scherr et al. 2011; 261 
Serrano-Ostáriz et al. 2009). Our results demonstrating greater pre- and post-exercise values 262 
of cTn in elite rowers than in amateur rowers. These data are consistent with our recent 263 
controlled endurance training intervention (Legaz-Arrese et al. 2015) and a field based study 264 
with marathoners (Saravia et al. 2010). Contradiction with previous studies may relate to 265 
differences in exercise regime, training status as well as the limited by the number of blood 266 
samples taken during the recovery period, in past work. 267 
There has been some descriptive association between peak post-exercise cTnI and mean 268 
exercise HR (Fu et al. 2009; Legaz-Arrese et al. 2011; Serrano-Ostáriz et al. 2009). 269 
Conversely, the higher absolute and relative work performed by the elite rowers in the 30 min 270 
exercise bout did not result in a greater change in cTnI during recovery when compared to 271 
amateur rowers. Overall there is no convincing evidence that exercise intensity mediated the 272 
cTnI response within the current research design.  273 
We do not know the reasons behind the higher cTnI baseline levels in elite vs. amateur 274 
rowers. A previous study also showed that runners with detectable hs-cTnT were 275 
significantly better trained than runners in whom hs-cTnT was non-detectable (Saravia et al. 276 
2010). Also, we observed that a controlled endurance training intervention resulted in higher 277 
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pre-exercise values of hs-cTnT (Legaz-Arrese et al. 2015). One hypothesis is that this effect 278 
is due to the successive training sessions with limited recuperation time for elite athletes. 279 
However, this seems unlikely to be a factor in this study because subjects were required to 280 
abstain from vigorous athletic activity for 48 h before each exercise test. Furthermore, if the 281 
greater baseline cTnI values were a consequence of incomplete recuperation, they ought to 282 
have similarly increased baseline levels of NT-proBNP, based on the results observed in this 283 
study. In a previous study, a significantly higher baseline hs-cTnT concentration was 284 
obtained in males compared to females (Mingels et al. 2009). Given that the mean heart size 285 
is larger for male and elite athletes than for female and amateur athletes (Legaz-Arrese et al. 286 
2006; Legaz Arrese et al. 2005), it is reasonable to expect different cTn reference values 287 
between these groups. Future research may wish to address this issue. 288 
 289 
Post-exercise NT-proBNP peak and kinetics in elite and amateur rowers 290 
This investigation is, to our knowledge, the first study that demonstrates NT-proBNP release 291 
as a consequence of a short-duration, high-intensity exercise in elite athletes. Increased NT-292 
proBNP has been reported in multiple prolonged endurance exercise studies (Legaz-Arrese et 293 
al. 2011; Neilan et al. 2006; Sahlén et al. 2008; Serrano-Ostáriz et al. 2009), and the current 294 
data extend this phenomenon to short-duration, high-intensity exercise. The observed 295 
increase are somewhat smaller than previous (ultra) endurance exercise studies (Neilan et al. 296 
2006; Serrano-Ostáriz et al. 2009) which may not be surprising when one considers that BNP 297 
is elevated in response to volume overload and myocyte stretch (Shave et al. 2007) and this is 298 
likely to be stressed to a much greater extent in endurance exercise. 299 
Our results demonstrate that like to cTnI, NT-proBNP values post exercise, as well as overall 300 
kinetic of appearance, is subject to a degree of heterogeneity. In agreement with the above 301 
mentioned study of Tian et al. (2012), levels of NT-proBNP increased immediately after 302 
Page 12 of 27
https://mc06.manuscriptcentral.com/apnm-pubs
Applied Physiology, Nutrition, and Metabolism
Draft
 
13 
exercise and were still elevated at 24 h. The elevation in NT-proBNP at 24 h reflects an 303 
increase beyond the kinetics of NT-proBNP and its half-life (Silver et al. 2004). Other factors 304 
associated with strenuous exercise, such as a temporary reduction in kidney function and 305 
changes in cardiac function and hemodynamics, have been suggested to contribute to a 306 
sustained elevation in NT-proBNP (Tian et al. 2012), but this requires further study.  307 
Our results show that although peak NT-proBNP data was heterogeneous the URL was not 308 
exceeded by any subject. Contrary to the data for cTnI there was no apparent difference in 309 
NT-proBNP between subject groups. In previous studies the influence of training level or 310 
athletic status on NT-proBNP release has been controversial (Herrmann et al. 2003; Legaz-311 
Arrese et al. 2011, 2015; Neilan et al. 2006; Scharhag et al. 2006; Serrano-Ostáriz et al. 312 
2009), likely because of the inability to precisely control for several variables, such as effort 313 
duration. Specifically, our study confirms previous results showing that the baseline NT-314 
proBNP is a key factor related to exercise-induced NT-proBNP increase (Carranza-García et 315 
al. 2011; Legaz-Arrese et al. 2011, 2015; Sahlén et al. 2008; Serrano-Ostáriz et al. 2011). 316 
Interestingly, we observed greater individual variability in time to peak NT-proBNP than for 317 
cTnI, and consequently, previous studies may significantly underestimate NT-proBNP 318 
release if a single post-exercise sample is taken. Future studies should be performed to 319 
determine NT-proBNP kinetics differences among individuals after different types of 320 
exertion. 321 
 322 
Implications  323 
The fact that cTnI elevation was observed in all, in the absence of any other signs or 324 
symptoms of cardiovascular disease as well as with a rapid onset of accumulation and 325 
recovery within the study period would add to the suggestion that this phenomenon is a 326 
normal physiological process. Clinicians should be aware regardless of athletic status, it is 327 
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possible to observe cTnI but not NT-proBNP values exceeding the URL in the first hours of 328 
recovery after a short-duration, high-intensity exercise period in a high percentage of 329 
individuals. Since cTnI is recommended as a sensitive and specific marker for cardiac 330 
damage in the diagnosis of acute myocardial infarction, caution should be taken when 331 
interpreting post-exercise cTnI levels. The results of this study are relevant for clinicians as it 332 
could improve medical decision making. 333 
 334 
Strengths and limitations  335 
Strengths of the present study include the controlled exercise regimen, matched elite and 336 
amateur rowers, serial blood sampling, and the inclusion of cTnI and NT-proBNP values. 337 
However, several limitations should be considered. Two of the rowers had cTnI above the 338 
URL pre-exercise. The study is limited by only having analyzed associations between 339 
biomarkers and athletic status in young male rowers. The impact of age and sex should be 340 
studies as factors that may partially mediate the release of cardiac biomarkers with exercise 341 
(Scharhag et al. 2008; Shave et al. 2010). The observed differences in the values of cTnI and 342 
NT-proBNP between elite and amateur rowers may have resulted from differences in the 343 
level of training but could also be associated with other factors, such as genetic differences. 344 
To resolve this issue, because of the difficulty of establishing a control group with athletes, it 345 
would be also interesting to observe in previously untrained subjects, the effect of training 346 
programs on exercise-induced cardiac biomarker release.   347 
 348 
Conclusions  349 
In conclusion, our results show that 30 min of high-intensity rowing results in the elevation 350 
of both cTnI and NT-proBNP across a 24 h recovery period. Whilst a rise in cTnI and NT-351 
proBNP was observed in all rowers, the peak values recorded were highly variable with some 352 
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cTnI data above URL. Kinetic data for cTnI were more consistent and there does not appear 353 
to be an important role for athlete or training status in mediating exercise biomarker 354 
responses beyond the impact of potential group differences in baseline data. 355 
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Figure Legends 477 
Fig. 1. Individual data points for cTnI (µg.L
-1
) in elite (n = 18) (a) and amateur (n = 14) (b) 
rowers at pre-exercise (PRE), as well as 0, 1, 3, 6, 12, and 24 h (0HR, 1HR, 3HR, 6HR, 
12HR, 24HR, respectively) after a 30 min maximal rowing test. The horizontal dotted line is 
the upper reference limit (99th percentile) at 0.04 µg.L
-1
. 
 
Fig. 2. Individual data points for NT-proBNP (ng.L
-1
) in elite (n = 18) (a) and amateur (n = 
14) (b) rowers at pre-exercise (PRE), as well as 0, 1, 3, 6, 12, and 24 h (0HR, 1HR, 3HR, 
6HR, 12HR, 24HR, respectively) after a 30 min maximal rowing test. All values were lower 
than the URL (125 ng.L
-1
). 
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Table 1. Participant characteristics by athletic status. 
 Age (years) Weight (kg) Height (cm) 
Rowing training 
history (years) 
Rowing training 
frequency 
(sessions/week) 
Rowing training 
volume 
(hours/week) 
Elite rowers 21.0 ± 4.1 77.9 ± 6.0 181.4 ± 6.0 8.2 ± 5.4* 6.9 ± 0.3* 22.1 ± 6.6* 
Amateur rowers 21.2 ± 2.0 76.6 ± 8.7 177.0 ± 9.0 3.7 ± 1.5 1.6 ± 0.5 2.9 ± 0.8 
Note: Values are means ± standard deviations (elite rowers: n = 18; amateur rowers: n = 14). * Significant differences between elite and amateur 
rowers. 
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Table 2. Performance during the maximal 30-min rowing test. 
 
0-5 min power 
(W) 
5-15 min power 
(W) 
15-25 min power 
(W) 
25-30 min power 
(W) 
Mean power (W) 
Percentage of max 
power (%) 
Elite rowers 260 ± 23* 254 ± 22* 251 ± 23* 286 ± 27* 259 ± 23* 88 ± 3* 
Amateur rowers 165 ± 48 156 ± 37 157 ± 33 179 ± 37 161 ± 36 76 ± 5 
Note: Values are means ± standard deviations (elite rowers: n = 18; amateur rowers: n = 14). * Significant differences between elite and amateur 
rowers. Similar pacing strategy was observed in both groups, with a significant increase in rowing performance in the last 5 min. 
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Table 3. cTnI (µg.L
-1
) and NT-proBNP (ng.L
-1
) before and after 30 min of high-intensity rowing exercise. 
  
Pre-
exercise 
5 min 
post 
1 h post 3 h post 6 h post 12 h post 24 h post 
p value 
Time Group 
Time x 
Group 
cTnI 
Elite 
rowers 
0.019 ± 
0.038 
(6) 
0.022 ± 
0.048 
(6) 
0.030 ± 
0.051 
(17) 
0.069 ± 
0.095 
(44) 
0.079 ± 
0.116 
(50) 
0.045 ± 
0.073 
(28) 
0.023 ± 
0.046 
(6) 
0.000 0.010 0.311 
Amateur 
rowers 
0.008 ± 
0.015 
(7) 
0.008 ± 
0.013 
(7) 
0.011 ± 
0.018 
(7) 
0.025 ± 
0.028 
(14) 
0.028 ± 
0.029 
(21) 
0.020 ± 
0.019 
(21) 
0.007 ± 
0.007 
(7) 
NT-
proBNP 
Elite 
rowers 
14 ± 11 
(0) 
25 ± 18 
(0) 
21 ± 16 
(0) 
19 ± 14 
(0) 
18 ± 12 
(0) 
18 ± 11 
(0) 
19 ± 14 
(0) 
0.001 0.322 0.171 
Amateur 
rowers 
17 ± 12 
(0) 
25 ± 19 
(0) 
25 ± 17 
(0) 
26 ± 18 
(0) 
26 ± 18 
(0) 
28 ± 18 
(0) 
27 ± 17 
(0) 
Note: Values are means ± standard deviations (elite rowers: n = 18; amateur rowers: n = 14). In brackets the percentage of subjects with serum 
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cardiac biomarkers exceeding the URL. 
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Fig. 1 
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Fig. 2 
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